Status:
COMPLETED
Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine Units.
Lead Sponsor:
Fadoi Foundation, Italy
Conditions:
Cardiovascular Events
Eligibility:
All Genders
18+ years
Brief Summary
FADOI-ICECAP is a observational, prospective, multicenter study involving 20-25 nationwide Units of Internal Medicine. The study foresees the participation of 26 Internal Medicine Operative Units, and...
Detailed Description
Phase 1 - Patients enrollment (October 2016 - February 2018) Each Investigator have recorded data concerning 50 patients. It will be collected general characteristics of patients, clinical parameters ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Diagnosis of pneumonia defined by the presence on chest X-ray or CT-scan of lung of new infiltration associated with at least two of the following clinical features:
- fever \> 37.8°C
- typical symptoms (dyspnea, productive cough, pain)
- typical clinical signs on chest examination (crepitation, bronchial breathing, pleural effusion)
- leukocytosis
Exclusion
- patients with Hospital-Acquired Pneumonia (HAP) (i.e. those patients with pneumonia acquired in hospital more than 48 hours after admission)
- patients with tuberculosis in active phase
- patients with cystic fibrosis
- patients who refuse to participate in the study and/or to give the written informed consent.
Key Trial Info
Start Date :
October 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 28 2018
Estimated Enrollment :
1266 Patients enrolled
Trial Details
Trial ID
NCT03798457
Start Date
October 1 2016
End Date
March 28 2018
Last Update
January 10 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.